Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity
| Data(s) |
18/01/2012
|
|---|---|
| Resumo |
Very preterm infants are prone to apnea and have an increased risk of death or disability. Caffeine therapy for apnea of prematurity reduces the rates of cerebral palsy and cognitive delay at 18 months of age. |
| Identificador | |
| Idioma(s) |
eng |
| Direitos |
info:eu-repo/semantics/restrictedAccess |
| Fonte |
Schmidt , B , Anderson , P J , Doyle , L W , Dewey , D , Grunau , R E , Asztalos , E V , Davis , P G , Tin , W , Moddemann , D , Solimano , A , Ohlsson , A , Barrington , K J , Roberts , R S & Caffeine for Apnea of Prematurity (CAP) Trial Investigators 2012 , ' Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity ' JAMA : the journal of the American Medical Association , vol 307 , no. 3 , pp. 275-82 . DOI: 10.1001/jama.2011.2024 |
| Palavras-Chave | #/dk/atira/pure/subjectarea/asjc/2700 #Medicine(all) |
| Tipo |
article |
